IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.
about
IFN-λ: A New Inducer of Local Immunity against Cancer and InfectionsInterferon-Lambda: A Potent Regulator of Intestinal Viral Infections.Interferon Lambda: Modulating Immunity in Infectious Diseases.Type I Interferons as Regulators of Lung Inflammation.Contribution of type III interferons to antiviral immunity: location, location, location.The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond.Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship.IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function.[Influenza and secondary bacterial infections: threats and treatments].Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.IFN-λ 'guts' neutrophil-mediated inflammation.Interferon Lambda Genetics and Biology in Regulation of Viral Control.Distinct Effects of Type I and III Interferons on Enteric Viruses.IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.IFN-λ and microRNAs are important modulators of the pulmonary innate immune response against influenza A (H1N2) infection in pigs.Host Immune Response to Influenza A Virus Infection.Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection.IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission.Interfering with transmission.Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System.Advancements in Host-Based Interventions for Influenza TreatmentTreating Influenza Infection, From Now and Into the Future
P2860
Q28072995-FB9DD049-79FB-4DBF-9F0C-142BEC420DBDQ33854465-6C2593AF-D010-4C42-BB38-2745604956A6Q37670446-05B3D6B6-8877-4AD0-9DFA-02C67720ACEFQ37691992-8D8BCEC1-100D-40B5-BFA8-30824313B8FBQ39176570-513314D0-311A-46DF-9E95-E5434DBD8374Q39223220-F8432A28-BA83-453C-9598-65666459D426Q39279748-0A7CB98D-2001-4BD8-870E-DCB6150831EAQ40054710-9DD1C2EC-ED5C-4E25-9A3D-BD2731A2B324Q40068221-CBD377E0-768E-42AB-A847-6A459EA86991Q40160725-CB818BC6-68AD-400D-A3AF-1A261307193EQ42369758-C4DD4D02-B938-4FC0-A919-9FAEF4B56BFAQ42602551-08FB6FCB-5FDB-4039-B9BB-93F288469C39Q47141979-1790214E-01EF-4BAF-8B78-499570CF2C2DQ47549718-214EDB14-3B16-4732-BCB1-836260C0CC80Q47600393-EB92A98A-0A95-4AAB-9ECA-68C2BC76713FQ52574395-CA9D327C-CAEA-4E6F-B7E6-02C9E4C08D34Q52647758-6B503644-2FA1-48E1-9188-987BDDD01CD9Q54210009-0ED15768-4EC4-40EB-B8A2-59A110F4D1EEQ54236514-9302EF98-5F4A-4E6F-A8CE-7920E756E56BQ55008072-1A942BA6-59E5-47C4-AECB-642772245B47Q55514867-2676C2A4-F596-46D2-AF93-00CCD239FD32Q56996774-6FFA4B57-D7D2-41CE-A8CE-9D79F546EA7CQ57158941-F1284883-CA93-4F0C-8E59-EFAE2DF2C2BA
P2860
IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
IFNλ is a potent anti-influenz ...... ide effects of IFNα treatment.
@en
type
label
IFNλ is a potent anti-influenz ...... ide effects of IFNα treatment.
@en
prefLabel
IFNλ is a potent anti-influenz ...... ide effects of IFNα treatment.
@en
P2860
P50
P356
P1476
IFNλ is a potent anti-influenz ...... side effects of IFNα treatment
@en
P2093
Sophia Davidson
P2860
P304
P356
10.15252/EMMM.201606413
P577
2016-09-01T00:00:00Z